Generic pharmaceutical companies need counsel who understand all aspects of their business.
Brinks' Hatch-Waxman litigation practice group clears the legal and regulatory pathway for our generic pharmaceutical clients. We leverage our legal experience and strong technical backgrounds to provide useful advice and solve the legal problems faced by the contemporary pharmaceutical marketplace.
We understand clients' top priorities, including responsiveness, efficiency, and budgeting. Litigation tactics must align with the client's business objectives; hence we invest the time to understand those objectives, and develop a litigation plan to achieve them.